Nucleic acid detection in pooled samples

• US 20080015112A1
• Filed: 02/15/2006
• Published: 01/17/2008
• Est. Priority Date: 05/09/2001
• Status: Abandoned Application

• Current Assignee: Bruce Neri, Lance Fors, Mary Brow, Monika Indig, Robert Roeven
• Original Assignee: Bruce Neri, Lance Fors, Mary Brow, Monika Indig, Robert Roeven
• Inventors: Neri, Bruce, Fors, Lance, Roeven, Robert, Indig, Monika, Brow, Mary
• Application Number:
  US11/355,090
• Publication Number:
  US 20080015112A1
• Time in Patent Office: Days
• US Class Current: 506/4
• CPC Class Codes: C12Q 1/6823 Release of bound markers
• CPC Class Codes: C12Q 1/6883 for diseases caused by alterations of genetic material
• CPC Class Codes: C12Q 1/703 Viruses associated with AIDS
• CPC Class Codes: C12Q 1/707 non-A, non-B Hepatitis, excluding hepatitis D
• CPC Class Codes: C12Q 2561/109 Invader technology
• CPC Class Codes: C12Q 2600/156 Polymorphic or mutational markers
• CPC Class Codes: G06Q 10/087 Inventory or stock management, e.g. order filling, procurement or balancing against orders
• CPC Class Codes: G06Q 30/06 Buying, selling or leasing transactions

Abstract

The present invention relates to detecting target nucleic acid sequences in pooled samples. In particular, the present invention relates to compositions and methods for detecting the presence or absence of target nucleic acid sequences (e.g. RNA virus sequences) in a pooled sample employing an INVADER detection assay. In certain embodiments, the present invention allows target nucleic acid sequence detection in pooled biological samples (e.g. pooled blood samples) without prior amplification of the target.

Claims

1. A method for detecting an allele frequency of a polymorphism in a target nucleic acid sequence, comprising:

a) providing;

i) a pooled sample, wherein said pooled sample comprises a plurality of target nucleic acids, each comprising an allele of said target nucleic acid sequence; and

ii) INVADER assay reagents configured to detect the presence or absence of a polymorphism in said target nucleic acid sequence; and

b) contacting said pooled sample with said INVADER assay reagents to generate a detectable signal; and

c) measuring said detectable signal, thereby determining a number of said target nucleic acid sequences that contain said polymorphism, wherein said allele frequency is determined from said number of said target nucleic acid sequences that contain said polymorphism.

2. The method of claim 1, wherein said plurality of target nucleic acids comprises at least 10.

3. The method of claim 2, wherein said at least 10 target nucleic acids comprises at least 1000.

4. The method of claim 2, wherein said at least 10 target nucleic acids comprises at least 10,000.

5. The method of claim 1, wherein said measuring comprises detection of fluorescence.

6. A method for detecting an allele frequency of a polymorphism in a target nucleic acid sequence, comprising:

a) providing;

i) a pooled sample, wherein said pooled sample comprises a plurality of target nucleic acids, each comprising at least one allele of said target nucleic acid sequence; and

ii) INVADER assay reagents configured to generate distinct signals for each different allele of said target nucleic acids; and

b) contacting said pooled sample with said INVADER assay reagents to generate a at least one distinct signal; and

c) measuring each of said at least one distinct signal, thereby determining a proportion of each allele of said polymorphic locus within said pooled sample, wherein said allele frequency is determined from said proportion.

7. The method of claim 6, wherein at least two distinct signals are generated for at least two different alleles of said target nucleic acid sequence, and wherein said measuring comprises comparing said at least two distinct signals.

8. The method of claim 7, wherein said at least two different alleles of said target nucleic acid sequence comprise a first allele and a second allele, wherein said first allele is present in said pooled sample at a ratio of 1:

1000 or less compared to said second allele.

9. The method of claim 8, said first allele is present in said pooled sample at a ratio of 1:

10,000 or less compared to said second allele.

10. The method of claim 6, wherein said measuring comprises detection of fluorescence.

11. The method of claim 7, wherein said comparing comprises applying a correction factor to a measurement of at least one distinct signal.

12. The method of claim 6, wherein said plurality of target nucleic acids are from a single individual.

13. The method of claim 12, wherein said plurality of target nucleic acids from a single individual comprise nucleic acids from a plurality of cells from said individual.

14. The method of claim 6, wherein said plurality of target nucleic acids comprise target nucleic acids from different individuals.

15. The method of claim 6, wherein said target nucleic acids are DNA.

16. The method of claim 6, wherein said target nucleic acids are RNA.

17. The method of claim 6, wherein said target nucleic acids are human nucleic acids.

18. The method of claim 17, wherein said human nucleic acids comprise nucleic acids from a plurality of human subjects.

19. The method of claim 6, wherein said target nucleic acids are from a plurality of microorganisms.

20. The method of claim 6, wherein said target nucleic acids are from a plurality of viruses.

21. The method of claim 6, further comprising, prior to step b), the step of performing polymerase chain reaction on said pooled sample such that said target nucleic acid sequence is amplified if present in said pooled sample.

22. The method of claim 6, wherein said target nucleic acid sequence is not amplified before said proportion of each allele of said polymorphic locus within said pooled sample target nucleic acid sequence is determined.